Hypothesis

7 Matching Annotations

Last 7 days
www.biorxiv.org www.biorxiv.org

CDK4/6 Inhibition Reverses MEIS2 Suppression of CRL4CRBN to Enhance Immunomodulatory Drug Therapy in Multiple Myeloma

1
1. scibot 21 Oct 2025
  
  in Public
  
  RRID:CVCL_1333
  
  DOI: 10.1101/2025.10.14.681840
  
  Resource: (DSMZ Cat# ACC-606, RRID:CVCL_1333)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1333
  
  What is this?
  
  RRID:CVCL_1333
Visit annotations in context

Tags

RRID:CVCL_1333

Annotators

scibot

URL

biorxiv.org/content/10.1101/2025.10.14.681840v1
Jul 2025
febs.onlinelibrary.wiley.com febs.onlinelibrary.wiley.com

Exploring the role of cyclin D1 in the pathogenesis of multiple myeloma beyond cell cycle regulation

1
1. scibot 25 Jul 2025
  
  in Public
  
  RRID:CVCL_1333
  
  DOI: 10.1002/1878-0261.70085
  
  Resource: (DSMZ Cat# ACC-606, RRID:CVCL_1333)
  
  Curator: @dhovakimyan1
  
  SciCrunch record: RRID:CVCL_1333
  
  What is this?
  
  RRID:CVCL_1333
Visit annotations in context

Tags

RRID:CVCL_1333

Annotators

scibot

URL

febs.onlinelibrary.wiley.com/doi/full/10.1002/1878-0261.70085
Jul 2024
www.sciencedirect.com www.sciencedirect.com

IRF4 requires ARID1A to establish plasma cell identity in multiple myeloma

1
1. scibot 24 Jul 2024
  
  in Public
  
  RRID:CVCL_1333
  
  DOI: 10.1016/j.ccell.2024.05.026
  
  Resource: (DSMZ Cat# ACC-606, RRID:CVCL_1333)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1333
  
  What is this?
  
  RRID:CVCL_1333
Visit annotations in context

Tags

RRID:CVCL_1333

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610824002174
Nov 2023
www.sciencedirect.com www.sciencedirect.com

Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies

1
1. scibot 28 Nov 2023
  
  in Public
  
  RRID:CVCL_1333
  
  DOI: 10.1016/j.ccell.2023.11.001
  
  Resource: (DSMZ Cat# ACC-606, RRID:CVCL_1333)
  
  Curator: @jmitrevska
  
  SciCrunch record: RRID:CVCL_1333
  
  What is this?
  
  RRID:CVCL_1333
Visit annotations in context

Tags

RRID:CVCL_1333

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S1535610823003665
Jul 2021
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov

Chromothripsis in Treatment Resistance in Multiple Myeloma

1
1. scibot 27 Jul 2021
  
  in Public
  
  KMS-12-PE
  
  DOI: 10.5808/GI.2017.15.3.87
  
  Resource: (DSMZ Cat# ACC-606, RRID:CVCL_1333)
  
  Curator: @mpairish
  
  SciCrunch record: RRID:CVCL_1333
  
  What is this?
  
  RRID:CVCL_1333 RRIDCUR:Missing
Visit annotations in context

Tags

RRIDCUR:Missing

RRID:CVCL_1333

Annotators

scibot

URL

ncbi.nlm.nih.gov/pmc/articles/PMC5637343/
Feb 2021
www.sciencedirect.com www.sciencedirect.com

Targeted degradation of the enhancer lysine acetyltransferases CBP and p300

1
1. scibot 28 Feb 2021
  
  in Public
  
  RRID:CVCL_1333
  
  DOI: 10.1016/j.chembiol.2020.12.004
  
  Resource: (DSMZ Cat# ACC-606, RRID:CVCL_1333)
  
  Curator: @scibot
  
  SciCrunch record: RRID:CVCL_1333
  
  What is this?
  
  RRID:CVCL_1333
Visit annotations in context

Tags

RRID:CVCL_1333

Annotators

scibot

URL

sciencedirect.com/science/article/pii/S2451945620305134
Sep 2020
pubmed.ncbi.nlm.nih.gov pubmed.ncbi.nlm.nih.gov

Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib

1
1. scibot 26 Sep 2020
  
  in Public
  
  RRID: CVCL_1333
  
  DOI: 10.3390/ijms21176314
  
  Resource: (DSMZ Cat# ACC-606, RRID:CVCL_1333)
  
  Curator: @evieth
  
  SciCrunch record: RRID:CVCL_1333
  
  What is this?
  
  RRID:CVCL_1333
Visit annotations in context

Tags

RRID:CVCL_1333

Annotators

scibot

URL

pubmed.ncbi.nlm.nih.gov/32878237/